跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
富马酸喹硫平缓释片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Quetiapine Fumarate Extended-Release Tablets
Approved
化学药品
Quetiapine Fumarate Extended-Release Tablets
ASTRAZENECA UK LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Sep 11, 2019
Approval ID
7MazXc2LU5L
Company
ASTRAZENECA UK LIMITED
Type
化学药品
Approval Details
Approval Id
7MazXc2LU5L
Approval Number
H20130887
Generic Name
富马酸喹硫平缓释片
Generic Name En
Quetiapine Fumarate Extended-Release Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
300mg
Reg Date
2019-09-11
Expired Date
2023-09-27
Company Name
ASTRAZENECA UK LIMITED
Company Address
Charter Way, Macclesfield, Cheshire SK10 2NA United Kingdom
Production Company Name
ASTRAZENECA PHARMACEUTICALS LP
Production Company Address
587 Old Baltimore Pike, Newark, DE 19702
Company Detail Path
/organization/astrazeneca-uk-limited
Production Company Detail Path
/organization/astrazeneca-pharmaceuticals-lp
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 11, 2019
Approval ID
7MazXc2LU5L
Type
化学药品
Back to NMPA Approvals